These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 51627)

  • 81. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells.
    Pearce NW; Spinelli A; Gurley KE; Dorsch SE; Hall BM
    J Immunol; 1989 Jul; 143(2):499-506. PubMed ID: 2472441
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Induction of antibody response to liposome-associated Gross-virus cell-surface antigen (GCSAa).
    Gerlier D; Sakai F; Doré JF
    Br J Cancer; 1980 Feb; 41(2):236-42. PubMed ID: 7370163
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Characterization of immune responses to spontaneous hamster lymphomas.
    Vasa-Thomas KA; Ambrose KR; Bellomy BB; Coggin JH
    J Natl Cancer Inst; 1977 May; 58(5):1287-93. PubMed ID: 67210
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Immunologic studies in virus-induced mouse and rat leukemia. II. Demonstration of a membrane-bound, group-specific leukemia antigen in Graffi and Gross leukemias of the mouse].
    Micheel B; Pasternak G; Bierwolf D
    Acta Biol Med Ger; 1972; 28(1):167-75. PubMed ID: 4114866
    [No Abstract]   [Full Text] [Related]  

  • 86. Immunological unresponsiveness to hepatic allografts in rats. Immunological reactivities of the recipient to donor antigens.
    Hasuike Y; Monden M; Valdivia LA; Kubota N; Nakano Y; Gotoh M; Okamura J; Mori T
    Transplantation; 1989 Jun; 47(6):1043-7. PubMed ID: 2660342
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F; Lilly F
    J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Failure to detect anti-group-specific murine leukemia virus activity in tetraparental AKR-CBA chimeras.
    Barnes RD; Tuffrey MA; Bourne RC
    Cancer Res; 1975 Oct; 35(10):2699-703. PubMed ID: 168964
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Tumour-associated transplantation antigens of neoplasms induced by a naturally occurring murine sarcoma virus (FBJ-MSV).
    Jones DB; Moore M
    Br J Cancer; 1973 Jun; 27(6):415-26. PubMed ID: 4516007
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Changes in cell surface properties during the in vivo growth of Moloney lymphoma.
    Fenyö EM; Peebles PT; Wahlström A; Klein E; Cochran AJ
    Isr J Med Sci; 1973 Mar; 9(3):239-50. PubMed ID: 4575651
    [No Abstract]   [Full Text] [Related]  

  • 91. Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response.
    De Landazuri MO; Herberman RB
    J Natl Cancer Inst; 1972 Jul; 49(1):147-54. PubMed ID: 5037432
    [No Abstract]   [Full Text] [Related]  

  • 92. Virion and non-virion murine leukemia membrane antigens: analysis with virus-absorbed antisera.
    Moroni C; Robert-Guroff M; Martin D
    Intervirology; 1974; 3(5-6):292-304. PubMed ID: 4443190
    [No Abstract]   [Full Text] [Related]  

  • 93. [The type specific antigen of Gross leukemia virus in tumors and normal tissues and its identification by immunodiffusion methods].
    Lezhneva OM
    Biull Eksp Biol Med; 1976 Feb; 81(2):217-9. PubMed ID: 819062
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T; Maruyama Y
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract]   [Full Text] [Related]  

  • 95. Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer.
    Bakouche O; Gerlier D
    Immunology; 1986 Feb; 57(2):219-23. PubMed ID: 3949369
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 97. Highly cytotoxic antisera obtained in W/Fu rats against a syngeneic Gross virus induced lymphoma.
    Gerlier D; Guibout C; Dore JF
    Eur J Cancer (1965); 1977 Aug; 13(8):855-9. PubMed ID: 908347
    [No Abstract]   [Full Text] [Related]  

  • 98. Use of an automatic cell harvester in a cellular radioimmunoassay.
    Gerlier D; Avice T
    J Immunol Methods; 1984 Dec; 75(1):159-66. PubMed ID: 6512263
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Selective cytotoxicity of two rodent T cell lymphomas to rat yolk sac tumours involves a retroviral envelope protein expressed by the lymphoma.
    Lindvall M; Eriksson H; Hedlund G; Sjögren HO
    Scand J Immunol; 1997 Nov; 46(5):479-87. PubMed ID: 9393630
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Gross virus leukemia in the rat: kinetics of infection and immunity.
    Ioachim HL
    Bibl Haematol; 1973; 39():288-95. PubMed ID: 4204858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.